These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20153849)

  • 21. Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.
    Zhang S; Kucharski C; Doschak MR; Sebald W; Uludağ H
    Biomaterials; 2010 Feb; 31(5):952-63. PubMed ID: 19878992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of bone morphogenetic protein-induced bone and cartilage formation on a new carrier: fibrous collagen membrane.
    Shigenobu K; Kaneda K; Nagai N; Kuboki Y
    Ann Chir Gynaecol Suppl; 1993; 207():85-90. PubMed ID: 8154842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro study on the osteogenesis enhancement effect of BMP-2 incorporated biomimetic apatite coating on titanium surfaces.
    Zhu X; Zhang H; Zhang X; Ning C; Wang Y
    Dent Mater J; 2017 Sep; 36(5):677-685. PubMed ID: 28883298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peri-implant osteogenesis in health and osteoporosis.
    Marco F; Milena F; Gianluca G; Vittoria O
    Micron; 2005; 36(7-8):630-44. PubMed ID: 16182543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated BMP-2 release from a novel dual-drug delivery system promotes bone formation.
    Liu T; Wu G; Zheng Y; Wismeijer D; Everts V; Liu Y
    Clin Oral Implants Res; 2014 Dec; 25(12):1412-21. PubMed ID: 25539008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
    Kodama T; Goto T; Miyazaki T; Takahashi T
    Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
    Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
    Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone tissue engineering on amorphous carbonated apatite and crystalline octacalcium phosphate-coated titanium discs.
    Dekker RJ; de Bruijn JD; Stigter M; Barrere F; Layrolle P; van Blitterswijk CA
    Biomaterials; 2005 Sep; 26(25):5231-9. PubMed ID: 15792550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histocompatibility of porous hydroxyapatite coating NiTi shape memory alloy].
    Zhang H; Wang S; Zhao B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Apr; 23(4):468-72. PubMed ID: 19431989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice.
    Nakamura Y; Tensho K; Nakaya H; Nawata M; Okabe T; Wakitani S
    Bone; 2005 Mar; 36(3):399-407. PubMed ID: 15777655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone formation in CaP-coated and noncoated titanium fiber mesh.
    Vehof JW; van den Dolder J; de Ruijter JE; Spauwen PH; Jansen JA
    J Biomed Mater Res A; 2003 Mar; 64(3):417-26. PubMed ID: 12579555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell and matrix reactions at titanium implants in surgically prepared rat tibiae.
    Masuda T; Salvi GE; Offenbacher S; Felton DA; Cooper LF
    Int J Oral Maxillofac Implants; 1997; 12(4):472-85. PubMed ID: 9274076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone formation by rat bone marrow cells cultured on titanium fiber mesh: effect of in vitro culture time.
    van den Dolder J; Vehof JW; Spauwen PH; Jansen JA
    J Biomed Mater Res; 2002 Dec; 62(3):350-8. PubMed ID: 12209920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of bone morphogenetic protein-2 gene therapy on the bone-implant interface: an experimental study with dogs].
    Yan MN; Tang TT; Zhu ZA; Zhou XS; Jia QW; Yu CF; Lou JR; Dai KR
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1521-5. PubMed ID: 16179108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
    Zachos TA; Shields KM; Bertone AL
    J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
    Zhu M; Zeng Y; Sun T; Peng Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in bone inducing activity of bone morphogenetic protein with aging.
    Bessho K; Iizuka T
    Ann Chir Gynaecol Suppl; 1993; 207():49-53. PubMed ID: 8154837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.